No images? Click here ![]() Additional pressures facing those chairing AIM Remuneration Committees – a less onerous regulatory regime and lighter time commitment compared to the main market, but not always an easier role to fulfil
The AIM market is home to companies from a wide range of countries, sectors, size and stages of development. AIM companies have access to a range of institutional and retail investors and are afforded lighter touch regulation, where NOMADs are tasked with regulating compliance with the AIM rules. But reduced levels of regulation, reporting and governance, and a greater diversity of shareholders produces more choice and often more questions in respect of remuneration design and governance. While the broad design of executive pay on the main market has become increasingly homogenous, this is not the case on AIM given this increased level of choice. When considering remuneration on AIM, there are very broadly three types of companies on AIM:
While each of these categories can be subdivided, they perhaps illustrate why pay practices on AIM are much more varied and why simply looking at median pay analysis without fully understanding these nuances can create issues. Accordingly, designing the most appropriate pay structure on AIM is likely to require more, rather than less, judgment. Being clear on which of these categories a company falls is likely to help in deciding on the appropriate answer to many of the questions posed in this briefing. This briefing sets out some of the most common questions posed to FIT by AIM Remuneration Committee Chairs which hopefully helps to demonstrate some of the challenges associated with the role. How much detail should AIM company Directors’ Remuneration Reports contain? While the disclosure requirements on the main market are highly prescriptive, this is not the case on AIM. Indeed, the AIM Rules do not require AIM-listed companies to publish a Directors’ Remuneration Report at all. The AIM Rules and UK Companies Act together do set out some minimal expected disclosures but this is limited compared to those required for main market companies. The QCA provides some guidance on content in its “Remuneration Committee Guide for Small and Mid-size Quoted Companies”, although much of this echoes main market practice and is, arguably, somewhat aspirational for all but the larger AIM companies. AIM-listed companies therefore have a spectrum of choices from: (i) the minimum remuneration disclosures required (these often sit in the notes to the financial statements rather than in a separate Directors’ Remuneration Report); (ii) a separate report mirroring the prescriptive disclosure requirements for main market companies (which can result in a Directors’ Remuneration Report running to circa 20 pages or more); or (iii) a balanced level of disclosure somewhere in between these two extremes. In FIT’s experience, the level of disclosure and length of the Directors’ Remuneration Report is normally correlated to the size of an AIM-listed company, with the very largest AIM companies often following much of the main market requirements (including separating the report into an Annual Statement, a Directors’ Remuneration Policy and the Annual Report on Remuneration) and the smaller AIM companies typically only providing one or two pages of remuneration-related disclosures. This is reflected in the disclosure statistics in respect of those companies voluntarily providing a separate Directors’ Remuneration Report – around 90% of companies in the AIM 100, 80% of companies in the AIM 101-200 and c.50% of the rest of AIM. However, market capitalisation and/or turnover is not a predictor of disclosure levels, and FIT is aware of several AIM companies which choose to keep remuneration disclosures to a minimum, believing that the greater the level of disclosure, the: (i) greater the risk of adverse feedback from shareholders and/or (ii) lower the flexibility that this affords the Committee on remuneration decisions. In practice, FIT’s experience is that most AIM companies will seek to be somewhere between main market and minimum disclosure levels. The challenge for a Remuneration Committee is striking the balance between trying to look and feel like a main market company and giving shareholders transparency on remuneration but without providing some of the more onerous disclosures. That said, the pressure is intensifying to disclose more on directors’ pay both from the proxy services such as ISS and Glass Lewis and a number of major AIM shareholders, particularly on base salary increases and how they compare with those for all employees, annual bonus targets/payouts and long-term incentive performance measures and targets. AIM-listed Remuneration Committees will therefore need to think about whether they wish to lead or lag the AIM market in this regard. Should AIM companies offer an advisory vote on the Directors’ Remuneration Report? Unlike main market practice, where companies are required to have an advisory vote on their Directors’ Remuneration Report every year, and a binding vote on their Directors’ Remuneration Policy at least every three years, there are no such requirements for an AIM Directors’ Remuneration Report to be put to a shareholder vote. That said, the QCA’s current guidance suggests that companies should consider holding an advisory shareholder vote to approve pay arrangements and many AIM companies voluntarily do this (around 50% of companies in the AIM 100, 40% of companies in the AIM 101-200 but only c.20% of the rest of AIM). In addition, we note that around two-thirds of companies which held a vote on remuneration in the last year chose to disclose the percentage of votes supporting the remuneration resolutions, with the remainder only disclosing whether or not a vote was passed. As remuneration is often considered to shed light on the wider governance of a company, many companies provide for a retrospective vote on remuneration with the hope of helping to broaden the existing shareholder base. Such an advisory vote has no real consequence on pay outcomes, but it does expose the company to reputational risk in the event of a significant vote against. Consistent with the thought process above, there is a subset of AIM-listed companies that do not wish to provide an advisory vote as they seek to minimise the opportunity for shareholders and proxies to influence remuneration. This tactic is not without its risks - if shareholders/proxies do have a concern regarding remuneration and there is no separate vote on remuneration, they will often recommend a vote against the resolution to approve the Annual Report instead (and this may be extended to votes against Directors as we have seen happen on the main market). Indeed, we have seen examples of companies where ISS has expressed its concerns on an amalgamation of “non-voting” points including remuneration and recommended a vote against the Annual Report, which has led to a significant vote against. Had the issues been spread over several resolutions, a significant vote against could have been avoided. A similar point can also be made in respect of whether to seek shareholder approval for the introduction of long-term incentive plans. While shareholder approval is required on the main market (assuming Executive Directors may participate and/or awards may be settled by new issue shares), there is no such requirement on AIM. As such, the introduction of new share plans, and amendments to existing share plans, are often done without shareholder approval (although clearly the NOMAD should be comfortable with this approach). How much coverage do AIM companies get from the proxies? Unlike the main market, the Investment Association does not cover AIM-listed companies. The main proxies covering AIM are Institutional Shareholder Services (“ISS”) and Glass Lewis which typically review AIM remuneration practice against a simpler version of the guidelines operated for the main market. ISS’ AIM guidelines tend to focus on material breaches of “best practice”, e.g. where service contracts provide for more than 12 months' notice; where Non-Executive Directors have received performance-related pay during the year under review; or where re-testing is allowed throughout the long-term incentive performance period. However, ISS:
Glass Lewis states that it aims to take a broadly similar approach to main market listed companies although it does recognise that the “remuneration structure and level of disclosure may be less developed at AIM-listed issuers than at larger, more established firms”. In FIT’s experience, while it is true that ISS and Glass Lewis tend to be less critical of AIM-listed companies outside of the AIM 50, and often the impact of a “vote against recommendation” is less material than on a main market company given a lower percentage of AIM shareholders follow these proxies closely, the risk of a surprise vote against recommendation on the Directors’ Remuneration Report, or Annual Report resolution if no separate vote, is arguably higher given the AIM guidance is less prescriptive. How much of main market practice should an AIM Remuneration Committee apply? While the overarching structure of a typical pay package – salary, benefits, pension, bonus and long-term incentives – has remained unchanged over the last ten years or so, in that period there have been a number of developments in practice in respect of main market directors’ pay packages. Such developments have often resulted from individual investors’ preferences (for example, the concept of post-vesting holding periods or post-cessation shareholding guidelines) or where proxies have taken a particular interest in certain concepts (e.g. ISS and minimum 200% of salary shareholding guidelines and the Investment Association and executive to workforce pension alignment). While some of these developments have been viewed as aspirational on AIM, others have become market, or at least good, practice:
Market value options, LTIPs or restricted shares? Despite efforts from different stakeholders not to straitjacket companies into one standard PLC model, the vast majority (75%) of main market companies operate an LTIP, aka a Performance Share Plan (i.e. grants of options at nil or nominal cost which vest after three years subject to service and performance) alongside an annual bonus plan. There has been a steady increase in companies moving to restricted shares (nil or nominal cost options that vest after three to five years subject to continued service only) but as things stand, this only makes up around 10% of the market. Only a handful of companies on the main market grant market value options (where the exercise price is equal to the award price). Practice on AIM is significantly more mixed:
Given the variation in countries, in practice and shareholder views (e.g. some AIM shareholders do not support the concept of nil or nominal cost options, preferring market value options instead), the structure – and for that matter the performance metrics – usually need careful consideration in the context of a company’s medium- to long-term strategy and shareholder base. Conclusion We hope that the above has demonstrated that acting as a Remuneration Committee Chair of an AIM-listed company can be just as challenging as the same role in a main market company. Reduced levels of regulation, reporting and governance, and a greater diversity of shareholders and views, produces more choice and often more questions in respect of remuneration design and governance. If you wish to discuss anything arising from this briefing, please ask your usual contact at FIT or call us on 020 7034 1111 or email us at Info@fit-rem.com. Rory Cray Darrell Hare Matt Higgins John Lee Sahul Patel Iain Scott Katharine Turner Matthew Ward This paper is intended to be a summary of key issues but is not comprehensive and does not constitute advice. No legal responsibility is accepted as a result of reliance on the contents of this paper. This email is confidential. If you are not the intended recipient, please delete the email and do not use it in any way. FIT Remuneration Consultants LLP (FIT) does not accept or assume responsibility for any use of or reliance on this email by anyone, other than the intended addressee to the extent agreed in the relevant contract for the matter to which this email relates (if any). Consistent with data protection regulations, if you would like to review our records relating to your contact details or to request their removal from our systems, please contact us at info@fit-rem.com. While all reasonable care has been taken to avoid the transmission of viruses, it is the responsibility of the recipient to ensure that the onward transmission, opening or use of this message and any attachments will not adversely affect its systems or data. No responsibility is accepted by FIT in this regard. FIT is a limited liability partnership registered in England under registered number OC364396, with its registered address at 1 Duke Street, London, W1U 3EA. |